Clinical Trials Logo

Venous Stasis Ulcer clinical trials

View clinical trials related to Venous Stasis Ulcer.

Filter by:

NCT ID: NCT01853384 Terminated - Ulcer Clinical Trials

Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers

Start date: November 2013
Phase: Phase 3
Study type: Interventional

This study is being done to find out if an investigational product called HP802-247 can help people with venous leg ulcers. Investigational means that HP802-247 has not been approved by the U.S. Food and Drug Administration (FDA). This research is being done to compare the efficacy of HP802-247 plus compression therapy against Vehicle plus compression therapy in achieving complete wound closure over the 12-week treatment period. Vehicle looks the same as HP802-247 but contains no cells. At least 440 subjects will participate. The study is going to be conducted in approximately 5 countries at approximately 50 sites across the European Union.

NCT ID: NCT01754506 Completed - Clinical trials for Venous Stasis Ulcers

Testing Fish Oil Derivatives In Healing Of Chronic Venous Leg Ulcers

Start date: January 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to test the efficacy of an oral, nutrient intervention containing the bioactive components of fish oil to promote healing of chronic venous leg ulcers (CVLU). If this systemic, nutrient intervention is found to alter the microenvironment of CVLU, the science of wound healing and care of patients with CVLU will be vastly improved.

NCT ID: NCT01612806 Terminated - Venous Stasis Ulcer Clinical Trials

A Multi-center, Prospective, Randomized Study With PriMatrix and PriMatrix Ag for the Treatment of Venous Leg Ulcers

Start date: June 2011
Phase: N/A
Study type: Interventional

To evaluate the effectiveness of PriMatrix, PriMatrix Ag, and Standard of Care in the treatment of venous leg ulcers (VLUs).

NCT ID: NCT01567150 Completed - Clinical trials for Venous Stasis Ulcers

Wound Fluid Protease Levels During Use of Novel Wound Dressing

Start date: February 2012
Phase: Phase 4
Study type: Interventional

This study is being conducted to characterize the way leg wounds respond to a new type of wound dressing, compared to wounds in patients who are not using the new dressing. The investigators will collect wound fluid for biochemical analysis, and they will measure the wound healing that occurs with and without the new dressing.

NCT ID: NCT01376050 Terminated - Venous Stasis Ulcer Clinical Trials

Efficacy Study of the Application of Low Level Laser Light to Treat Venous Stasis Ulcers

Start date: June 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether low level laser light therapy is effective as an adjunctive therapy to the healing of venous stasis leg ulcers.

NCT ID: NCT01129986 Completed - Clinical trials for Venous Stasis Ulcers

A Post Marketing Clinical Study Utilizing DermaStream and Saline in Venous Ulcers

Start date: June 2009
Phase: N/A
Study type: Interventional

An open-label, prospective, controlled, two-step approach, post-marketing clinical study, applying DermaStream with saline streaming, in conjunction with a sustained multi-compression wrap, on healthy individuals and on patients with a venous stasis ulcer of the lower extremity.

NCT ID: NCT01113658 Withdrawn - Clinical trials for Diabetic Foot Ulcers

Clinical Evaluation of the SNaP Wound Care System

Start date: March 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the efficacy of design improvements of the Spiracur SNaP Wound Care System. This study prospectively evaluates the safety and efficacy of current and new design iterations of components of the FDA-cleared Spiracur SNaP Wound Care System in order to optimize safety, efficacy, and system performance.

NCT ID: NCT01050023 Active, not recruiting - Clinical trials for Venous Stasis Ulcers

Provant Therapy of Venous Stasis Ulcer Trial

Start date: November 2009
Phase: N/A
Study type: Interventional

This pilot study hypothesizes that use of the Regenesis Provant Wound Therapy System (a radiofrequency device) twice daily over venous stasis ulcers (wounds thought to occur due to improper functioning of valves in the veins, usually of the legs) will result in increased rates of healing and a larger proportion of completely healed wounds after 12 weeks of therapy compared to wounds treated identically using a Provant device that is not activated to emit radiofrequency.

NCT ID: NCT00900029 Completed - Venous Leg Ulcer Clinical Trials

Safety Follow-Up to HP 802-247-09-015

Start date: June 2009
Phase: N/A
Study type: Observational

The objective of this study is to examine the durability of previous target wound closures, identify new test article-related adverse events, record new target wound closures, and examine ongoing adverse events not resolved in subjects who participated in HP 802-247-09-015.

NCT ID: NCT00858130 Completed - Clinical trials for Deep Vein Thrombosis

Pilot Study for VeinoPlus to Improve Symptoms of Postthrombotic Syndrome (PTS)

VeinoPlus
Start date: March 2009
Phase: N/A
Study type: Interventional

The investigators plan to perform an exploratory study to investigate the effects of electro-stimulation of the legs on the symptoms and clinical findings of post thrombotic syndrome (PTS), as well as quality of life of patients with PTS. The investigators theorize that electro-stimulation will provide both a mechanical benefit via muscular contraction and increased venous outflow from the affected extremity, as well as an anesthetic effect, which the investigators anticipate will translate into improved symptomatic outcomes, quality of life (QOL) benefits.